Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 10 hours ago
Braveheart aims for freedom with IPO to support Hengrui-licensed cardio asset
about 10 hours ago
It appears Braveheart Bio isn’t going to let Big Pharma take its...
Big Pharma-backed AdvanCell, flush with $315M series D, ready to put radiotherapy pedal to the metal
about 14 hours ago
Less than a month after locking down a lease for a new...
J&J axes eye disease gene therapy after key phase 2b readout
about 14 hours ago
Johnson & Johnson has stopped development of an eye disease gene therapy...
J&J MedTech growth slows again in Q2 as Abiomed weighs on results
about 15 hours ago
Johnson & Johnson’s MedTech business posted operational sales growth of 3.6% in...
Medtronic recalls catheter delivery system that may detach and cause death
about 16 hours ago
Medtronic issued a voluntary recall of 102 lots of its Harmony delivery...
AAIC: Roche ‘very interested’ in testing tau for Alzheimer’s despite focus on phase 3-stage amyloid drug
about 16 hours ago
Roche’s biggest bet in the Alzheimer’s disease space may be its phase...
Attovia files for IPO to take on Sanofi and Regeneron’s Dupixent
about 20 hours ago
Attovia Therapeutics has filed for an IPO to secure funding for assets...
Study shows promise of brain interface training to aid neuropsychiatric patients
about 22 hours ago
Brain-computer interface training, which uses feedback from electrical activity in the brain...
With FDA approval for its breast cancer blockbuster hopeful, Celcuity could ‘belong in the hands’ of a Big Pharma
1 day ago
The FDA has approved a new small molecule inhibitor from Celcuity with...
FDA plans to release more drug rejection letters as controversial policy resumes
1 day ago
After pausing a controversial policy to publicly release drug rejection letters in...
Biogen defends anti-tau drug after stock slides on Alzheimer’s readout
1 day ago
Biogen leaders took to an investor call today to defend the phase...
CEPI-backed Ebola vaccine set to enter phase 1 trials
1 day ago
The first vaccine against the Bundibugyo ebola virus is poised to enter...